EUVIMEDEUVIMED entdecken
Crossref

Fecal Short-Chain Fatty Acids in Young Children and Their Mothers Are Not Associated With Progression to Islet Autoimmunity

Bree J Tillett, Min Yan, Dovile Anderson, Vivian Zhang, Darren Creek, Simon C Barry, Peter G Colman, Jennifer J Couper, Maria E Craig, Elizabeth A Davis, Aveni Haynes, Tony Huynh und 14 weitere

Diabetes Care · 01.11.2026 · 49 (11) · 1973-1981

DOI: 10.2337/dc26-0516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 07.08.2026. Verfasst von Bree J Tillett und 25 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Woolloongabba, Queensland, Australia. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Feces, Diabetes Mellitus, Type 1, Islets of Langerhans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Diabetes Australia, National Health and Medical Research Council of Australia, JDRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Reduced microbial short-chain fatty acids (SCFA) have been implicated in type 1 diabetes (T1D) risk. We investigated fecal SCFA concentrations in mother-infant dyads from pregnancy to the onset of islet autoimmunity (IA) to test whether decreased fecal SCFA concentrations increase IA risk. RESEARCH DESIGN AND METHODS Children with a first-degree relative with T1D and their mothers were followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) pregnancy-birth cohort study. A nested case-control design included n = 54 infant case subjects that developed one or more persistent islet autoantibodies/clinical T1D and n = 161 age- and sex-matched control subjects without IA. Stool (n = 1,120 samples) from each pregnancy trimester in mothers (median n = 2 samples) and from birth in infants (median n = 6 samples) up until IA onset were used to quantify SCFA by liquid chromatography–mass spectrometry. Weighted conditional logistic regression and linear mixed-effects models investigated associations between SCFA and IA onset. RESULTS Fecal SCFA were not associated with IA onset, and SCFA profiles through pregnancy and early childhood were similar between case subjects and control subjects. Infant fecal SCFA concentrations increased until age 1 year. Introduction of solid foods significantly increased acetate (false discovery rate [FDR] = 0.000028) and summed primary SCFA (FDR = 0.00784) concentrations. Higher infant BMI z scores correlated with higher fecal acetate (FDR = 0.0767) and butyrate (FDR = 0.0590). Mothers with T1D had lower acetate (FDR = 0.0696), butyrate (FDR = 0.0959), and propionate (FDR = 0.0696) than mothers without T1D during pregnancy. Concentrations of these three SCFA were lower in infants of mothers with versus without T1D (FDR = 0.0073, 0.0603, and 0.0479, respectively). CONCLUSIONS These data do not support that lower fecal SCFA concentrations across pregnancy and early life are directly associated with IA development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, VolatileFecesDiabetes Mellitus, Type 1Islets of LangerhansAutoimmunityHumansFemalePregnancyInfantCase-Control StudiesAdultMaleChild, PreschoolMothers

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Woolloongabba, Queensland, Australia.
  • Monash Proteomics and Metabolomics Platform, Monash University, Melbourne, Victoria, Australia.
  • Robinson Research Institute and School of Medicine, College of Health, Adelaide University, North Adelaide, South Australia, Australia.
  • Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Endocrinology and Diabetes Department, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
  • Discipline of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

ORCID-Profile: Emma E Hamilton-Williams

Förderung

  • Diabetes Australia
  • National Health and Medical Research Council of Australia
  • JDRF

Zitieren

APA

Tillett, B. J., Yan, M., Anderson, D., Zhang, V., Creek, D., Barry, S. C., Colman, P. G., Couper, J. J., Craig, M. E., Davis, E. A., Haynes, A., Huynh, T., Kim, K. W., Morahan, G., Penno, M. A. S., Rawlinson, W. D., Soldatos, G., Spelman, T., Thomson, R. L., …, & ENDIA Study Group (2026). Fecal Short-Chain Fatty Acids in Young Children and Their Mothers Are Not Associated With Progression to Islet Autoimmunity. Diabetes Care, 49(11), 1973-1981. https://doi.org/10.2337/dc26-0516

Vancouver

Tillett BJ, Yan M, Anderson D, Zhang V, Creek D, Barry SC, et al. Fecal Short-Chain Fatty Acids in Young Children and Their Mothers Are Not Associated With Progression to Islet Autoimmunity. Diabetes Care. 2026;49(11):1973-1981. doi:10.2337/dc26-0516

BibTeX
@article{Tillett2026,
  author = {Tillett, Bree J and Yan, Min and Anderson, Dovile and Zhang, Vivian and Creek, Darren and Barry, Simon C and Colman, Peter G and Couper, Jennifer J and Craig, Maria E and Davis, Elizabeth A and Haynes, Aveni and Huynh, Tony and Kim, Ki Wook and Morahan, Grant and Penno, Megan A S and Rawlinson, William D and Soldatos, Georgia and Spelman, Timothy and Thomson, Rebecca L and Tye-Din, Jason and Vuillermin, Peter J and Wentworth, John M and Harrison, Leonard C and Oakey, Helena and Hamilton-Williams, Emma E and ENDIA Study Group, ENDIA Study Group},
  title = {Fecal Short-Chain Fatty Acids in Young Children and Their Mothers Are Not Associated With Progression to Islet Autoimmunity},
  journal = {Diabetes Care},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1973--1981},
  doi = {10.2337/dc26-0516}
}
Kostenlos starten →